Adare Pharma Solutions is a contract development and manufacturing organization (CDMO) headquartered in Philadelphia that provides end-to-end services for oral dosage forms, from early-stage development through commercial manufacturing and packaging. The company operates seven facilities across the United States and Europe, serving a global customer base with more than 65 products currently sold worldwide.
The firm specializes in patient-centric dosing solutions, offering proprietary technology platforms for taste masking, customized release profiles, solubility enhancement, and modified formulations designed for specific patient populations including children, the elderly, and those with swallowing difficulties. Adare maintains cGMP-compliant manufacturing environments in both the US and Europe and holds DEA licenses for the manufacture and testing of controlled substances.
With nearly 800 employees globally, Adare operates as a technology-driven organization backed by private equity. The company's integrated service model allows customers to leverage both manufacturing expertise and specialized formulation capabilities across the product lifecycle.
